K2 Principal Fund’s Akcea Therapeutics Inc AKCA Stock Holding History

K2 Principal Fund’s Portfolio AKCA Stock Details AKCA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-58,853	Closed	-$1.07M	–	439
2020 Q3	$1.07M	Buy	+58,853	New	+$835K	0.16%	143

K2 Principal Fund's AKCA Position: Q4 2020 in Review

K2 Principal Fund sold out of Akcea Therapeutics Inc (AKCA) in Q4 2020, closing a stake of 58,853 shares — an estimated $1.07M sold.

K2 Principal Fund first reported a position in AKCA in Q3 2020 and held it in 1 quarter. The position peaked at $1.07M in Q3 2020. 0 funds tracked by Wall St. Rank hold AKCA as of Q4 2020.

K2 Principal Fund reported no remaining Akcea Therapeutics Inc position as of Q4 2020 after selling out during the quarter.
K2 Principal Fund sold 58,853 Akcea Therapeutics Inc shares in Q4 2020, an estimated $1.07M.
K2 Principal Fund first reported a position in Akcea Therapeutics Inc in Q3 2020 and held it in 1 quarter.
K2 Principal Fund's Akcea Therapeutics Inc position peaked at $1.07M in Q3 2020.
0 funds tracked by Wall St. Rank held Akcea Therapeutics Inc as of Q4 2020.

Based on K2 Principal Fund's 13F filing for Q4 2020, filed 12 Feb 2021.